Evaluating the effects of switching from dutasteride to tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms: A randomized, open-label, multicenter study

被引:2
|
作者
Matsumoto, Teppei [1 ]
Hatakeyama, Shingo [1 ]
Narita, Takuma [1 ]
Yoneyama, Takahiro [1 ]
Hashimoto, Yasuhiro [1 ]
Ohyama, Chikara [1 ]
机构
[1] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori, Japan
基金
日本学术振兴会;
关键词
discontinuation; dutasteride; lower urinary symptom; oxidative stress; tadalafil; MEN; DISCONTINUATION; INHIBITOR; BLOCKER;
D O I
10.1111/iju.13908
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:522 / 523
页数:2
相关论文
共 50 条
  • [21] EFFECTS OF TADALAFIL ON STORAGE AND VOIDING FUNCTION IN PATIENTS WITH MALE LOWER URINARY TRACT SYMPTOMS SUGGESTIVE OF BENIGN PROSTATIC HYPERPLASIA, BASED ON A URODYNAMIC STUDY
    Matsukawa, Y.
    Majima, T.
    Funahashi, Y.
    Matsuo, K.
    Yamamoto, T.
    Gotoh, M.
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 : S250 - S251
  • [22] Re: Effects of Tadalafil on Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia in Men With or Without Erectile Dysfunction
    Yachia, Daniel
    EUROPEAN UROLOGY, 2010, 58 (06) : 942 - 943
  • [23] Early improvement of storage or voiding symptoms by tadalafil predicts treatment outcomes in patients with lower urinary tract symptoms from benign prostatic hyperplasia
    Yokoyama, Osamu
    Ozeki, Akichika
    Suzuki, Nahoko
    Murakami, Masahiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (03) : 240 - 245
  • [24] THE ASSESSMENT OF TADALAFIL EFFECT ON LOWER URINARY TRACT SYMPTOMS SUGGESTIVE OF BENIGN PROSTATIC HYPERPLASIA IN PATIENTS TREATED WITH STANDARD MEDICATION
    Madani, Hamidi A.
    Afsharimoghaddam, A.
    Roushani, A.
    Farzan, A.
    Asadollahzadeh, A.
    Shakiba, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 123 - 123
  • [25] Technological innovation of HoLEP: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia
    Gao, Zhixiang
    Wang, Ping
    Liu, Haiyong
    Ding, Yue
    Xu, Li
    Sun, Zhiwei
    Du, Renji
    Gu, Lijuan
    Shen, Yajun
    Wang, Rong
    WORLD JOURNAL OF UROLOGY, 2025, 43 (01)
  • [26] The Effects of Chlormadinone Acetate on Lower Urinary Tract Symptoms and Erectile Functions of Patients with Benign Prostatic Hyperplasia: A Prospective Multicenter Clinical Study
    Fujimoto, Kiyohide
    Hirao, Yoshihiko
    Ohashi, Yasuo
    Shibata, Yasuhiro
    Fuji, Kohzo
    Tsuji, Hidenori
    Miyazawa, Katsuhito
    Ohtani, Mikinobu
    Furuya, Ryoji
    Boku, Eitetsu
    ADVANCES IN UROLOGY, 2013, 2013
  • [27] Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia
    Michel, MC
    Mehlburger, L
    Schumacher, H
    Bressel, HU
    Goepel, M
    JOURNAL OF UROLOGY, 2000, 163 (06): : 1725 - 1729
  • [28] Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
    McNaughton-Collins, M
    Barry, MJ
    AMERICAN JOURNAL OF MEDICINE, 2005, 118 (12): : 1331 - 1339
  • [29] Randomized Controlled Trial to Assess the Efficacy of the Combination Therapy of Alfuzosin and Tadalafil in Patients with Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
    Kumar, Santosh
    Kondareddy, Chilekampalli
    Ganesamoni, Raguram
    Nanjappa, Bhuvanesh
    Singh, Shrawan K.
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2014, 6 (01) : 35 - 40
  • [30] Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A dose finding study
    Roehrborn, Claus G.
    McVary, Kevin T.
    Elion-Mboussa, Albert
    Viktrup, Lars
    JOURNAL OF UROLOGY, 2008, 180 (04): : 1228 - 1234